M1 KLINIKEN AG O.N./ DE000A0STSQ8 /
| 10/10/2024 9:38:08 AM | Chg. +0.300 | Volume | Bid9:39:21 AM | Ask9:38:08 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 16.700EUR | +1.83% | 4,002 Turnover: 66,504.950 |
16.600Bid Size: 167 | 16.800Ask Size: 392 | 328.04 mill.EUR | 2.99% | 30.93 |
Assets
|
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 16 | 15.8000 | 15.3000 | 17.1770 | 13.7930 | ||||||
| Intangible Assets | .4000 | 4 | 60.4000 | 25.9710 | 25.2360 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | - | - | - | 89.7170 | 102.3640 | ||||||
| Inventories | 1.5000 | 42.3000 | 35.2000 | 27.5860 | 45.5260 | ||||||
| Accounts Receivable | 22.2000 | 20.5000 | 16.3000 | 21.7730 | 28.0200 | ||||||
| Cash and Cash Equivalents | 9.1000 | 22 | 37.9000 | 35.1460 | 22.3800 | ||||||
| Current Assets | 59.3000 | 122.4000 | 110.2000 | 107.3060 | 110.5880 | ||||||
| Total Assets | 92.8000 | 188.7000 | 198.1000 | 197.0240 | 212.9520 | ||||||
Liabilities
|
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 7.8000 | 15.8000 | 12.8000 | 19.2210 | 33.2560 | ||||||
| Long-term debt | - | - | - | 3.1250 | 1.8750 | ||||||
| Liabilities to Banks | .2000 | 22.3000 | 14.8000 | - | - | ||||||
| Provisions | 2.1000 | 3.9500 | 4.1600 | 4.3630 | 3.1650 | ||||||
| Liabilities | 24.6000 | 73.5000 | 58.2000 | 53.9740 | 69.7290 | ||||||
| Share Capital | 17.5000 | 19.6000 | 19.6000 | - | - | ||||||
| Total Equity | 68.2000 | 115.3000 | 139.9000 | 95.5200 | 113.2500 | ||||||
| Minority Interests | 0.0000 | 0.0000 | 0.0000 | 47.5300 | 29.9730 | ||||||
| Total liabilities equity | 92.8000 | 188.7000 | 198.1000 | 197.0240 | 212.9520 | ||||||
Income Statement
|
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 77.2000 | 159.6000 | 314.6000 | 285.2910 | 316.3180 | ||||||
| Depreciation (total) | 3.4000 | 4.5000 | 5.7000 | 6.0620 | 5.3100 | ||||||
| Operating Result | 7.9000 | 4.4000 | 12.1000 | 9.3470 | 15.6990 | ||||||
| Interest Income | -.2200 | -.4000 | -.2000 | -.1860 | -.5630 | ||||||
| Income Before Taxes | 12.7000 | 8.8000 | 14.4000 | - | - | ||||||
| Income Taxes | 3 | 1.4000 | 3.5000 | 3.1630 | 4.7790 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 2.7520 | 1.3920 | ||||||
| Net Income | 9.7000 | 7.4000 | 10.9000 | 4.3170 | 10.2740 | ||||||
Per Share
Cash Flow
|
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -5.4000 | 9.5000 | 15.7000 | 20.7680 | 7.8090 | ||||||
| Cash Flow from Investing Activities | -3.3000 | 3.1000 | .2000 | -1.1160 | -9.3630 | ||||||
| Cash Flow from Financing | -7.6000 | .3000 | .5000 | -22.3670 | -14.8080 | ||||||
| Decrease / Increase in Cash | -16.3000 | 8.9000 | 19.9000 | - | - | ||||||
| Employees | 236 | 428 | 350 | 366 | 219 | ||||||
